MAPK14 and COVID-19: However, it was recently reported that during COVID-19, inhibition of p38 MAPK resulted in suppressed cytokine production, and impaired viral replication by a still unknown mechanism, suggesting that p38 inhibition may target multiple mechanisms related to COVID-19's pathogenesis [6, 14].